Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bernhard Scheiner

Showing results (61-70 of 203) with videos related to

Pageof 21
Sort By:
Thrombosis and Haemostasis|May 21, 2021
Intraperitoneal Activation of Coagulation and Fibrinolysis in Patients with Cirrhosis and AscitesJohannes Thaler, Ton Lisman, Peter Quehenberger, et al.
Journal of Hepatology|March 1, 2023
Anticoagulation improves survival in patients with cirrhosis and portal vein thrombosis: The IMPORTAL competing-risk meta-analysisAntonio Guerrero, Laura Del Campo, Fabio Piscaglia, et al.
United European Gastroenterology Journal|June 19, 2019
Ascitic fluid polymorphic nuclear cell count impacts on outcome of cirrhotic patients with ascitesBenedikt Simbrunner, Annika Röthenbacher, Helmuth Haslacher, et al.
JHEP Reports : Innovation in Hepatology|April 10, 2023
Dysregulated biomarkers of innate and adaptive immunity predict infections and disease progression in cirrhosisBenedikt Simbrunner, Lukas Hartl, Mathias Jachs, et al.
Hepatology International|March 7, 2023
Bacterial translocation occurs early in cirrhosis and triggers a selective inflammatory responseBenedikt Simbrunner, Esther Caparrós, Teresa Neuwirth, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|February 14, 2020
The impact of ABO blood type on the prevalence of portal vein thrombosis in patients with advanced chronic liver diseaseBernhard Scheiner, Patrick G Northup, Anselm B Gruber, et al.
Scandinavian Journal of Gastroenterology|May 24, 2017
Non-selective beta-blocker treatment does not impact on kidney function in cirrhotic patients with varicesBernhard Scheiner, Diego Parada-Rodriguez, Theresa Bucsics, et al.
Journal of Gastroenterology|December 11, 2021
Distinct prognostic value of different portal hypertension-associated features in patients with primary biliary cholangitisLukas Burghart, Emina Halilbasic, Philipp Schwabl, et al.
Journal of Gastroenterology and Hepatology|May 8, 2019
Impact of farnesoid X receptor single nucleotide polymorphisms on hepatic decompensation and mortality in cirrhotic patients with portal hypertensionGeorg Semmler, Benedikt Simbrunner, Bernhard Scheiner, et al.
Wiener Klinische Wochenschrift|July 27, 2017
Non-invasive liver fibrosis assessment and HCV treatment initiation within a systematic screening program in HIV/HCV coinfected patientsDavid Chromy, Philipp Schwabl, Theresa Bucsics, et al.
Pageof 21

Showing results (61-70 of 203) with videos related to

Sort By:
Pageof 21
Thrombosis and Haemostasis|May 21, 2021
Intraperitoneal Activation of Coagulation and Fibrinolysis in Patients with Cirrhosis and AscitesJohannes Thaler, Ton Lisman, Peter Quehenberger, et al.
Journal of Hepatology|March 1, 2023
Anticoagulation improves survival in patients with cirrhosis and portal vein thrombosis: The IMPORTAL competing-risk meta-analysisAntonio Guerrero, Laura Del Campo, Fabio Piscaglia, et al.
United European Gastroenterology Journal|June 19, 2019
Ascitic fluid polymorphic nuclear cell count impacts on outcome of cirrhotic patients with ascitesBenedikt Simbrunner, Annika Röthenbacher, Helmuth Haslacher, et al.
JHEP Reports : Innovation in Hepatology|April 10, 2023
Dysregulated biomarkers of innate and adaptive immunity predict infections and disease progression in cirrhosisBenedikt Simbrunner, Lukas Hartl, Mathias Jachs, et al.
Hepatology International|March 7, 2023
Bacterial translocation occurs early in cirrhosis and triggers a selective inflammatory responseBenedikt Simbrunner, Esther Caparrós, Teresa Neuwirth, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|February 14, 2020
The impact of ABO blood type on the prevalence of portal vein thrombosis in patients with advanced chronic liver diseaseBernhard Scheiner, Patrick G Northup, Anselm B Gruber, et al.
Scandinavian Journal of Gastroenterology|May 24, 2017
Non-selective beta-blocker treatment does not impact on kidney function in cirrhotic patients with varicesBernhard Scheiner, Diego Parada-Rodriguez, Theresa Bucsics, et al.
Journal of Gastroenterology|December 11, 2021
Distinct prognostic value of different portal hypertension-associated features in patients with primary biliary cholangitisLukas Burghart, Emina Halilbasic, Philipp Schwabl, et al.
Journal of Gastroenterology and Hepatology|May 8, 2019
Impact of farnesoid X receptor single nucleotide polymorphisms on hepatic decompensation and mortality in cirrhotic patients with portal hypertensionGeorg Semmler, Benedikt Simbrunner, Bernhard Scheiner, et al.
Wiener Klinische Wochenschrift|July 27, 2017
Non-invasive liver fibrosis assessment and HCV treatment initiation within a systematic screening program in HIV/HCV coinfected patientsDavid Chromy, Philipp Schwabl, Theresa Bucsics, et al.
Pageof 21